CLOs on the Move

Q2 Solutions

www.q2labsolutions.com

 
Q² Solutions, a Quintiles Quest joint venture Launched in 2015, Q² Solutions (pronounced Q-squared) is a leading global clinical trials laboratory services organization. We help biopharmaceutical, medical device and diagnostics customers improve human health through innovation that transforms science and data into actionable medical insights. Q² Solutions is a quality driven, responsive partner with strong global experience and deep scientific and medical expertise. The Q² Solutions joint venture was formed by Quintiles and Quest Diagnostics, combining the best of each parent organizations clinical trials laboratory services capabilities.
  • Number of Employees: 1K-5K
  • Annual Revenue: > $1 Billion

Executives

Name Title Contact Details

Similar Companies

Sameday Health

Sameday Health is dedicated to healthcare as a complete experience, not simply a service. Our purpose is to create healthcare that centers around the client, combining a human approach with intuitive technology. We offer quality, personalized care wherever you are including in our clinics or at your door.

Burgess Health Center

Burgess Health Center is committed to improve the quality of life for the people and communities we serve by providing excellent healthcare and exceptional patient experiences.

NotifyMD

NotifyMD is a Franklin, TN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Fister Lauberth

Fister Lauberth is a Saint Louis, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Naveos

NAVEOS® is the proven leader in maximizing the value of governmental program reimbursements for healthcare providers. Since 2005, our superior approach to data analytics has enabled healthcare providers to realize almost one billion dollars in additional DSH/340B reimbursement payments. NAVEOS® has developed a fully integrated DSH/340B software solution with a national eligibility verification network for both Medicare and Medicaid data. This system, which is the most robust in the industry, uses sophisticated algorithms to match eligibility data with patient data, applies the most up to date Federal and State regulatory parameters, then builds comprehensive deliverables for supporting DSH/340B filings. By leveraging our state-of-the-art technology and unsurpassed domain expertise, we generate best-in-class deliverables that yield impressive value and achieve a stellar (99.7%) audit acceptance rate.